Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: A systematic review and meta analysis

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 5, 2012, Pages 672-678

  Qin, Q ^a   Xie, Z ^a   Shen, Y ^a   Yang, S ^a   Liu, C ^a   Huang, Z ^a   Xu, J ^a   Ai, J ^a   Shen, K ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Epstein Barr virus; Hematopoietic stem cell transplantation; Hemophagocytic lymphohistiocytosis; Meta analysis

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; IMMUNOGLOBULIN;

CLINICAL ASSESSMENT; EPSTEIN BARR VIRUS; FOLLOW UP; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNOTHERAPY; MEDLINE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; REFERENCE DATABASE; REVIEW; RISK; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; WHOLE BODY RADIATION; ADOLESCENT; AGE; CHILD; EPSTEIN BARR VIRUS INFECTION; EVIDENCE BASED MEDICINE; FEMALE; IMMUNOLOGY; INFANT; MALE; METHODOLOGY; PATHOGENICITY; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; ETOPOSIDE; EVIDENCE-BASED MEDICINE; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOTHERAPY; INFANT; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; STEM CELL TRANSPLANTATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864081807     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. COHEN JI. Epstein-Barr virus infection. N Engl J Med 2000, 343: 481-492.
2. HENTER JI, ARICO M, EGELER RM, ELINDER G, FAVARA BE, FILIPOVICH AH, GADNER H, IMASHUKU S, JANKA-SCHAUB G, KOMP D, LADISCH S, WEBB D. HLH-94 a treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1997; 28: 342-347.
3. IMASHUKU S. Clinical features and treatment strategies of Epstein-Barr virus associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002; 44: 259-272.
4. HENTER JI, SAMUELSSON-HORNE A, ARICO M, EGELER RM, ELINDER G, FILIPOVICH AH, GADNER H, IMASHUKU S, KOMP D, LADISCH S, WEBB D, JANKA G; HISTOCYTE SOCIETY. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373.
5. SUMEGI J, HUANG D, LANYI A, DAVIS JD, SEEMAYER TA, MAEDA A, KLEIN G, SERI M, WAKIGUCHI H, PURTILO DT, GROSS TG. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood 2000; 96: 3118-3125.
6. IMASHUKU S, NAYA M, YAMORI M, NAKABAYASHI Y, HOJO M, KIHARA A, TABATA Y, AKIOKA C, HIBI S, TODO S. Bone marrow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis. Bone Marrow Transplant 1997; 19: 1059-1060.
7. OHGA S, KUDO K, ISHII E, HONJO S, MORIMOTO A, OSUGI Y, SAWADA A, INOUE M, TABUCHI K, SUZUKI N, ISHIDA Y, IMASHUKU S, KATO S, HARA T. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Pediatr Blood Cancer 2010; 54: 299-306.
8. JIN YK, XIE ZD, YANG S, LU G, SHEN KL. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: A retrospective study of 78 pediatric cases in mainland of China. Chin Med J (Engl) 2010; 123: 1426-1430.
9. LEE WI, CHEN SH, HUNG IJ, YANG CP, JAING TH, CHEN CJ, LI SP, HUANG JL. Clinical aspects, immunologic assessment, and genetic analysis in Taiwanese children with hemophagocytic lymphohistiocytosis. Pediatr Infect Dis J 2009; 28: 30-34.
10. BEUTEL K, GROSS-WIELTSCH U, WIESEL T, STADT UZ, JANKA G, WAGNER HJ. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr Blood Cancer 2009; 53: 184-190.
11. SATO E, OHGA S, KURODA H, YOSHIBA F, NISHIMURA M, NAGASAWA M, INOUE M, KAWA K. Allogeneic hematopoietic stem cell transplantation for Epstein- Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan. Am J Hematol 2008; 83: 721-727.
12. YANG J, ZHANG Y, XIE Z, YANG S. Analysis of 26 cases with EBV-associated hemophagocytic lymphohistiocytosis. J China Pediatr Blood Cancer 2007; 12: 157-160.
13. LEE JS, KANG JH, LEE GK, PARK HJ. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol. J Korean Med Sci 2005; 20: 209-214.
14. IMASHUKU S, TERAMURA T, TAUCHI H, ISHIDA Y, OTOH Y, SAWADA M, TANAKA H, WATANABE A, TABATA Y, MORIMOTO A, HIBI S, HENTER JI. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica 2004; 89: 183-188.
15. IMASHUKU S, TERAMURA T, KURIYAMA K, KITAZAWA J, ITO E, MORIMOTO A, HIBI S. Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Int J Hematol 2002; 75: 174-177.
16. IMASHUKU S, HIBI S, TABATA Y, ITOH E, HASHIDA T, TSUNAMOTO K, ISHIMOTO K, KAWANO F. Outcome of clonal hemophagocytic lymphohistiocytosis: Analysis of 32 cases. Leuk Lymphoma 2000; 37: 577-584.
17. IMASHUKU S, HIBI S, TODO S, SAKO M, INOUE M, KAWA K, KOIKE K, IWAI A, TSUCHIYA S, AKIYAMA Y, KOTANI T, KAWAMURA Y, HIROSAWA M, HASEGAWA D, KOSAKA Y, YAMAGUCHI H, ISHII E, KATO K, ISHII M, KIGASAWA H. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant 1999; 23: 569-572.
18. BELYEA B, HINSON A, MORAN C, HWANG E, HEATH J, BARFIELD R. Spontaneous resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2010; 55: 754-756.
19. IMASHUKU S, HIBI S, OHARA T, IWAI A, SAKO M, KATO M, ARAKAWA H, SOTOMATSU M, KATAOKA S, ASAMI K, HASEGAWA D, KOSAKA Y, SANO K, IGARASHI N, MARUHASHI K, ICHIMI R, KAWASAKI H, MAEDA N, TANIZAWA A, ARAI K, ABE T, HISAKAWA H, MIYASHITA H, HENTER JI. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood 1999; 93: 1869-1874.
20. IMASHUKU S, KURIYAMA K, TERAMURA T, ISHII E, KINUGAWA N, KATO M, SAKO M, HIBI S. Requirement for etoposide in the treatment of Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001; 19: 2665-2673.
21. CHEN JS, LIN KH, LIN DT, CHEN RL, JOU ST, SU IJ. Longitudinal observation and outcome of non-familial childhood haemophagocytic syndrome receiving etoposide-containing regimens. Br J Haematol 1998; 103: 756-762.
22. IMASHUKU S, HIBI S, TODO S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997; 130: 352-357.
23. MY LT, LIEN B, HSIEH WC, IMAMURA T, ANH TN, ANH PN, HUNG NT, TSENG FC, CHI CY, DAO NT, LE DT, THINH LE Q, TUNG TT, IMASHUKU S, THUONG TC, SU IJ. Comprehensive analyses and characterization of haemophagocytic lymphohistiocytosis in Vietnamese children. Br J Haematol 2010; 148: 301-310.
24. IMASHUKU S, HIBI S, KURIYAMA K, TABATA Y, HASHIDA T, IWAI A, KATO M, YAMASHITA N, ODA MUCHIDA M, KINUGAWA N, SAWADA M, KONNO M. Management of severe neutropenia with cyclosporin during initial treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH). Leuk Lymphoma 2000; 36: 339-346.
25. TAKAHASHI T, YAGASAKI F, ENDO K, TAKAHASHI M, ITOH Y, KAWAI N, KUSUMOTO S, MUROHASHI I, BESSHO M, HIRASHIMA K. Therapy-related AML after successful chemotherapy with low dose etoposide for virusassociated hemophagocytic syndrome. Int J Hematol 1998; 68: 333-336.
26. IMASHUKU S, TERAMURA T, MORIMOTO A, HIBI S. Recent developments in the management of haemophagocytic lymphohistiocytosis. Expert Opin Pharmacother 2001; 2: 1437-1448.
27. BOLME P, HENTER JI, WINIARSKI J, ELINDER G, LJUNGMAN P, LÖNNERHOLM G, RINGDÉN O. Allogeneic bone marrow transplantation for hemophagocytic lymphohistiocytosis in Sweden. Bone Marrow Transplant 1995; 15: 331-335.
28. OKAMURA T, HATSUKAWA Y, ARAI H, INOUE M, KAWA K. Blood stem cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet 2000; 356: 223-224.